141 related articles for article (PubMed ID: 10703320)
1. Extravasation of infusate via implanted ports: two case studies.
Viale PH; Yamamoto DS; Geyton JE
Clin J Oncol Nurs; 1999 Oct; 3(4):145-51. PubMed ID: 10703320
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risks of infiltration and extravasation.
Rosenthal K
Nursing; 2007; 37 Suppl Med():4-8. PubMed ID: 18163033
[No Abstract] [Full Text] [Related]
4. Complications associated with implantable vascular access devices in the patient with cancer.
Viale PH
J Infus Nurs; 2003; 26(2):97-102. PubMed ID: 12642798
[TBL] [Abstract][Full Text] [Related]
5. Advances in venous access devices and nursing management strategies.
Wickham RS
Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
[TBL] [Abstract][Full Text] [Related]
6. Long-term central venous catheters: issues for care.
Wickham R; Purl S; Welker D
Semin Oncol Nurs; 1992 May; 8(2):133-47. PubMed ID: 1621004
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive power Doppler-mediated diagnosis of catheter leakage in a totally implanted venous access port.
Brücher BL; Stock K; Weiss W; Ungeheuer A; Erdmann J; Lersch C
J Ultrasound Med; 2005 Jan; 24(1):109-11. PubMed ID: 15615936
[No Abstract] [Full Text] [Related]
8. Additional issues raised on blood returns and ports.
Morris DJ
Oncol Nurs Forum; 2000 Sep; 27(8):1202-3. PubMed ID: 11013901
[No Abstract] [Full Text] [Related]
9. Vesicant extravasation part II: Evidence-based management and continuing controversies.
Wickham R; Engelking C; Sauerland C; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
[TBL] [Abstract][Full Text] [Related]
10. Venous access ports: frequency and management of complications in oncology patients.
Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
[TBL] [Abstract][Full Text] [Related]
11. Hoarseness: an unusual complication of port-A catheter perforation.
Wang JC; Tsai SH; Chan CY; Wan HL
Onkologie; 2012; 35(3):122-4. PubMed ID: 22414977
[TBL] [Abstract][Full Text] [Related]
12. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
Parran L
Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
[No Abstract] [Full Text] [Related]
13. Emergency! Chemotherapy extravasation.
Navarro TM
Am J Nurs; 1998 Nov; 98(11):38. PubMed ID: 9826933
[No Abstract] [Full Text] [Related]
14. Vesicant extravasation from an implanted venous access port.
Wickham R
Oncology (Williston Park); 2009 Apr; 23(4 Suppl Nurse Ed):34-8. PubMed ID: 19856596
[TBL] [Abstract][Full Text] [Related]
15. Extravasation: prevention, recognition and management.
Dougherty L
Nurs Stand; 2010 Sep 1-7; 24(52):48-55; quiz 56, 60. PubMed ID: 20860215
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
Mayo DJ; Pearson DC
Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
[TBL] [Abstract][Full Text] [Related]
17. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
Bach F; Videbaek C; Holst-Christensen J; Boesby S
Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
[TBL] [Abstract][Full Text] [Related]
18. I.V. infiltration: not just a peripheral problem.
Hadaway LC
Nursing; 2002 Aug; 32(8):36-42; quiz 43. PubMed ID: 12352849
[No Abstract] [Full Text] [Related]
19. Cytostatic extravasation. A serious complication of long-term venous access.
Bach F; Videbaek C; Holst-Christensen J; Boesby S
Cancer; 1991 Aug; 68(3):538-9. PubMed ID: 2065273
[TBL] [Abstract][Full Text] [Related]
20. A flow sheet for follow-up after chemotherapy extravasation.
Davis ME; DeSantis D; Klemm K
Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
